당뇨병성감각운동다발신경병에서 전기진단검사의 진료지침

키워드

참고문헌 (40)

1. "Report and recommendations of the san antonio conference on diabetic neuropathy", Ann Neurol, 24, pp.99~104 (1988)
2. Thomas PK, "Classification, differential diagnosis, and staging of diabetic peripheral neuropathy", Diabetes, 46(Suppl 2), pp.54~57 (1997)
3. Boulton AJ, "Diabetic neuropathies: A statement by the american diabetes association", Diabetes Care, 28, pp.956~962 (2005)
4. England JD, "Distal symmetric polyneuropathy: A definition for clinical research: Report of the american academy of neurology, the american association of electrodiagnostic medicine, and the american academy of physical medicine and rehabilitation", Neurology, 64, pp.199~207 (2005)
5. Tesfaye S, "Diabetic neuropathies: Update on definitions, diagnostic criteria, estimation of severity, and treatments", Diabetes Care, 33, pp.2285~2293 (2010)
6. 김남순, "한국형 임상진료지침 평가도구", 임상진료지침 지원국, ~
7. Pirart J, "diabetes mellitus and its degenerative complications: A prospective study of 4,400 patients observed between 1947 and 1973 (3rd and last part) (author’s transl)", Diabete Metab, 3, pp.245~256 (1977)
8. Maser RE, "Epidemiological correlates of diabetic neuropathy. Report from pittsburgh epidemiology of diabetes complications study", Diabetes, 38, pp.1456~1461 (1989)
9. Knuiman MW, "Prevalence of diabetic complications in relation to risk factors", Diabetes, 35, pp.1332~1339 (1986)
10. Dyck PJ, "Longitudinal assessment of diabetic polyneuropathy using a composite score in the rochester diabetic neuropathy study cohort", Neurology, 49, pp.229~239 (1997)
11. Dyck PJ, "Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry", Ann Neurol, 8, pp.590~596 (1980)
12. Meijer JW, "Symptom scoring systems to diagnose distal polyneuropathy in diabetes: The diabetic neuropathy symptom score", Diabet Med, 19, pp.962~965 (2002)
13. Dyck PJ, "Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: A study of three cohorts. Nerve growth factor study group", Diabetes Care, 23, pp.510~517 (2000)
14. Meijer JW, "Clinical diagnosis of diabetic polyneuropathy with the diabetic neuropathy symptom and diabetic neuropathy examination scores", Diabetes Care, 26, pp.697~701 (2003)
15. Dyck PJ, "The rochester diabetic neuropathy study: Reassessment of tests and criteria for diagnosis and staged severity", Neurology, 42, pp.1164~1170 (1992)
16. Meijer JW, "Diabetic neuropathy examination: A hierarchical scoring system to diagnose distal polyneuropathy in diabetes", Diabetes Care, 23, pp.750~753 (2000)
17. Kahn R., "Proceedings of a consensus development conference on standardized measures in diabetic neuropathy", Muscle Nerve, 15, pp.1143~1143 (1992)
18. Ogawa K, "Peripheral nerve functions may deteriorate parallel to the progression of microangiopathy in diabetic patients", Nutr Metab Cardiovas, 16, pp.313~321 (2006)
19. Hamalainen H, "Factors predicting lower extremity amputations in patients with type 1 or type 2 diabetes mellitus: A populationbased 7-year follow-up study", J Intern Med, 246, pp.97~103 (1999)
20. Elliott J, "Large-fiber dysfunction in diabetic peripheral neuropathy is predicted by cardiovascular risk factors", Diabetes Care, 32, pp.1896~1900 (2009)
21. Brown MJ, "Natural progression of diabetic peripheral neuropathy in the zenarestat study population", Diabetes Care, 27, pp.1153~1159 (2004)
22. Carrington AL, "Can motor nerve conduction velocity predict foot problems in diabetic subjects over a 6-year outcome period?", Diabetes Care, 25, pp.2010~2015 (2002)
23. Hotta N, "Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: The 3-year, multicenter, comparative aldose reductase inhibitor-diabetes complications trial", Diabetes Care, 29, pp.1538~1544 (2006)
24. Malik RA, "Effect of angiotensin-convertingenzyme (ace) inhibitor trandolapril on human diabetic neuropathy: Randomised double-blind controlled trial", Lancet, 352, pp.1978~1981 (1998)
25. Apfel SC, "Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. Rhngf clinical investigator group", JAMA, 284, pp.2215~2221 (2000)
26. Bril V, "Long-term effects of ranirestat (as-3201) on peripheral nerve function in patients with diabeticsensorimotor polyneuropathy", Diabetes Care, 29, pp.68~72 (2006)
27. Kelkar P, "Distinctive pathologic findings in proximal diabetic neuropathy (diabetic amyotrophy)", Neurology, 55, pp.83~88 (2000)
28. Dyck PJ, "Microvasculitis and ischemia in diabetic lumbosacral radiculoplexus neuropathy", Neurology, 53, pp.2113~2121 (1999)
29. Stewart JD., "Diabetic truncal neuropathy: Topography of the sensory deficit", Ann Neurol, 25, pp.233~238 (1989)
30. Vinik A, "Focal entrapment neuropathies in diabetes", Diabetes Care, 27, pp.1783~1788 (2004)
31. England JD, "Practice parameter: Evaluation of distal symmetric polyneuropathy: Role of laboratory and genetic testing (an evidence-based review). Report of the american academy of neurology, american association of neuromuscular and electrodiagnostic medicine, and american academy of physical medicine and rehabilitation", Neurology, 72, pp.185~192 (2009)
32. Smith AG, "The diagnostic yield of a standardized approach to idiopathic sensory-predominant neuropathy", Arch Intern Med, 164, pp.1021~1025 (2004)
33. Novella SP, "The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy", Muscle Nerve, 24, pp.1229~1231 (2001)
34. "Technology review: The neurometer current perception threshold (cpt).", Muscle Nerve, 22, pp.523~531 (1999), Aaem equipment and computer committee. American association of electrodiagnostic medicine
35. Veves A, "The relationship between sural nerve morphometric findings and measures of peripheral-nerve function in mild diabetic neuropathy", Diabetic Med, 8, pp.917~921 (1991)
36. Putz Z, "Noninvasive evaluation of neural impairment in subjects with impaired glucose tolerance", Diabetes Care, 32, pp.181~183 (2009)
37. Pambianco G, "The assessment of clinical distal symmetric polyneuropathy in type 1 diabetes: A comparison of methodologies from the pittsburgh epidemiology of diabetes complications cohort", Diabetes Res Clin Pract, 92, pp.280~287 (2011)
38. Malik RA, "Sural nerve pathology in diabetic patients with minimal but progressive neuropathy", Diabetologia, 48, pp.578~585 (2005)
39. Lauria G, "European federation of neurological societies", peripheral nerve society guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the european fe-deration of neurological societies and the peripheral nerve society, 2010, pp.17, 903~949
40. England JD, "Evaluation of distal symmetric polyneuropathy: The role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review)", Muscle Nerve, 39, pp.106~115 (2009)

관련 논문AI추천